[HTML][HTML] Ventilator-associated pneumonia in adults: a narrative review

L Papazian, M Klompas, CE Luyt - Intensive care medicine, 2020 - Springer
Ventilator-associated pneumonia (VAP) is one of the most frequent ICU-acquired infections.
Reported incidences vary widely from 5 to 40% depending on the setting and diagnostic …

[HTML][HTML] Update of the treatment of nosocomial pneumonia in the ICU

R Zaragoza, P Vidal-Cortés, G Aguilar, M Borges… - Critical Care, 2020 - Springer
In accordance with the recommendations of, amongst others, the Surviving Sepsis
Campaign and the recently published European treatment guidelines for hospital-acquired …

Nanoparticle-modified microrobots for in vivo antibiotic delivery to treat acute bacterial pneumonia

F Zhang, J Zhuang, Z Li, H Gong, BEF de Ávila… - Nature materials, 2022 - nature.com
Bioinspired microrobots capable of actively moving in biological fluids have attracted
considerable attention for biomedical applications because of their unique dynamic features …

[HTML][HTML] Inhaled amikacin to prevent ventilator-associated pneumonia

S Ehrmann, F Barbier, J Demiselle… - … England Journal of …, 2023 - Mass Medical Soc
Background Whether preventive inhaled antibiotics may reduce the incidence of ventilator-
associated pneumonia is unclear. Methods In this investigator-initiated, multicenter, double …

Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 …

M Klompas, R Branson, K Cawcutt, M Crist… - Infection Control & …, 2022 - cambridge.org
The purpose of this document is to highlight practical recommendations to assist acute care
hospitals to prioritize and implement strategies to prevent ventilator-associated pneumonia …

[HTML][HTML] Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: a proof-of-concept study

D Annane, N Heming, L Grimaldi-Bensouda… - …, 2020 - thelancet.com
Background Complement pathway inhibition may provide benefit for severe acute
respiratory illnesses caused by viral infections such as COVID-19. We present results from a …

[HTML][HTML] Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated …

G Blonz, A Kouatchet, N Chudeau, E Pontis, J Lorber… - Critical care, 2021 - Springer
Background The COVID-19 pandemic is responsible for many hospitalizations in intensive
care units (ICU), with widespread use of invasive mechanical ventilation (IMV) which …

[HTML][HTML] Diagnosis of ventilator-associated pneumonia in critically ill adult patients—a systematic review and meta-analysis

SM Fernando, A Tran, W Cheng, M Klompas… - Intensive care …, 2020 - Springer
The accuracy of the signs and tests that clinicians use to diagnose ventilator-associated
pneumonia (VAP) and initiate antibiotic treatment has not been well characterized. We …

[HTML][HTML] Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation

A De Bruyn, S Verellen, L Bruckers, L Geebelen… - BMC infectious …, 2022 - Springer
Background Patients infected with severe acute respiratory syndrome coronavirus (SARS-
CoV-2) can develop severe illness necessitating intensive care admission. Critically ill …

Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update

M Klompas, R Branson, EC Eichenwald… - Infection Control & …, 2014 - cambridge.org
Previously published guidelines are available that provide comprehensive
recommendations for detecting and preventing healthcare-associated infections (HAIs). The …